Age and memory B cells at baseline are associated with risk of relapse and memory B-cell reappearance following anti-CD20 treatment in pediatric frequently-relapsing/steroid-dependent nephrotic syndrome-Reference-Cited by-同舟云学术

Age and memory B cells at baseline are associated with risk of relapse and memory B-cell reappearance following anti-CD20 treatment in pediatric frequently-relapsing/steroid-dependent nephrotic syndrome

Published:2023-09 Issue:3 Volume:104 Page:577-586
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Colucci Manuela,Angeletti Andrea,Zotta Federica,Carsetti Rita,Lugani Francesca,Ravà Lucilla,Ravani Pietro,Emma Francesco,Ghiggeri Gian Marco,Vivarelli Marina

Publisher

Elsevier BV

Subject

Nephrology

Reference35 articles.

1. Idiopathic nephrotic syndrome in children;Noone;Lancet,2018

2. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial;Iijima;Lancet,2014

3. Anti-CD20 antibodies for idiopathic nephrotic syndrome in children;Ravani;Clin J Am Soc Nephrol,2016

4. Human or chimeric monoclonal anti-CD20 antibodies for children with nephrotic syndrome: a superiority randomized trial;Ravani;J Am Soc Nephrol,2021

5. Rituximab in children with steroid sensitive nephrotic syndrome: in quest of the optimal regimen;Chan;Pediatr Nephrol,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Effective treatment of rituximab-resistant minimal change disease with obinutuzumab in an adult;Frontiers in Immunology;2024-07-29

2. Can we effectively manage chronic kidney disease with a precision-based pharmacotherapy plan? Where are we?;Expert Opinion on Pharmacotherapy;2024-06-12

3. Rituximab versus tacrolimus as corticosteroid-sparing therapy for children with steroid-dependent nephrotic syndrome: A systematic review and meta-analysis of randomized and nonrandomized controlled trials;Tzu Chi Medical Journal;2024-04-24

4. Management of adult patients with podocytopathies: an update from the ERA Immunonephrology Working Group;Nephrology Dialysis Transplantation;2024-02-10